Anglo-Nordic Biotech Conference III in London
Unique collaboration opportunities between the UK and Scandinavia
Conference Programme 2006
Moderator: Mr Perry Yam, Partner, SJ Berwin LLP, Corporate Finance Department
| 09.30 - 10.00 | Registration and coffee |
| 10.00 - 10.10 | Conference Introduction – Mr Perry Yam, Partner, SJ Berwin LLP |
| 10.10 – 10.20 |
Welcome on behalf of the Nordic Trade Councils and UK Trade & Investment - Mr Tom Risdahl Jensen, Ambassador of Denmark Dr Rob Morgan, Director, DTI Bioscience Unit |
| 10.20 - 11.40 | Elevator Pitches (4 company presentations) - Affitech, Martin Welschof, CEO - Bionor Immuno, Dr Birger Sørensen, CEO - ENKAM Pharmaceuticals, Morten Albrechtsen, CEO - Lyfjathroun hf, Thora Bjorg Magnusdottir, CEO |
| 11.40 - 12.10 |
(Case Study) Successful International Pharmaceutical agreements – NicOx S.A's Ophthalmology Deal with Pfizer , presented by Damian Marron, Vice President Corporate Development, NicOx and Andrew Shindler, Partner, SJ Berwin LLP. Read the Case Study press release |
| 12.10 - 13.30 | Lunch |
| 13.30 - 14.00 | (Case Study) Successful M & A venture shares its experience from the M&A process – Dr. Sanjay Kakkar, CEO, Trigen Ltd |
| 14.00 – 15.00 | Elevator Pitches (3 company presentations) - Neuronova, Johan Häggblad, Head of Business Development - NsGene, Bo Karmark, Chief Financial Officer - Tripep, Anders Vahlne, Head of Research |
| 15.00– 15.30 | Latest news from the Venture Capital Industry (US versus Europe) – Dr Nessan Bermingham, Principle of Life Sciences, Atlas Venture LLP |
| 15.30 - 16.00 | Q & A and panel discussions |
| 16.00 - 19.00 | Buffet and drinks |
Press here for a printable version of the schedule
Elevator Pitches
Affitech - "Creating a therapeutic antibody pipeline through technology-based collaborations and partnerships", Martin Welschof, CEO
Bionor Immuno -
"HIV immunotherapy - presentation of clinicial phase II data." ,
Dr Birger Sørensen, CEO
ENKAM Pharmaceuticals - "generating novel treatments for neurodegenerative disorders and cancer”, Morten Albrechtsen, CEO
Lyfjathroun hf - "Nasal drug delivery. Rapid systemic effect without the needle.", Þóra Björg Magnúsdóttir
Neuronova - "Therapeutic neurogenesis, new paradigm and treatment opportunity for neurology indications.",
Johan Häggblad,
Head Business Development
NsGene - "unique biodelivery technology to treat neurological disorders",
Jens Viktor Nørgaard, Director of Intellectual Property Rights
Tripep - "New approaches for the treatment of HIV and hepatitis C virus infections", Anders Vahlne, Head of Research
For a list of the attending companies press here
There will also be pre-arranged one-to-one meetings going on during the day.